Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas R. Malek is active.

Publication


Featured researches published by Thomas R. Malek.


Cellular Immunology | 1984

Interleukin 2-driven T lymphocyte proliferation is dependent upon a surface antigen distinct from the interleukin 2 receptor: Requirements for inhibition of T-cell proliferation by monoclonal antibody 5C3

Thomas R. Malek; Ethan M. Shevach

A monoclonal antibody (5C3) to an antigen expressed on activated guinea pig T lymphocytes that did not react with the interleukin 2 (IL-2) receptor, but inhibited IL-2-driven proliferative responses has been previously characterized. The present study provides further analysis of the inhibitory capacity of 5C3 for T-cell proliferation and of the relationship between the expression of the antigen defined by 5C3 and the capacity of cells to respond to IL-2. 5C3 inhibited proliferation of T-cell blasts to IL-2-containing fluids when added as late as 8 hr prior to termination of a 26-hr culture. 5C3 pretreatment of the IL-2-responsive blast cells was also sufficient to detect significant inhibition of proliferation. FACS analysis of these blasts indicated that maximal 5C3 binding was required for pretreatment to result in inhibition of IL-2-driven proliferation. Delayed addition of 5C3 to culture or pretreatment with 5C3 of responding cells also resulted in inhibition of proliferation of immune T lymphocytes to antigen-pulsed-presenting cells. Lastly, although modulated 5C3- blasts failed to proliferate to IL-2, induction of the 5C3-bearing molecule on these 5C3- blasts correlated with restoration of the ability of these cells to proliferate to IL-2. Collectively, these results further support the hypothesis that monoclonal antibody 5C3 interferes with a critical signal in the IL-2 growth pathway.


Archive | 1984

The Role of Macrophages in the Processing and Presentation of Protein Antigens to T Lymphocytes

Thomas R. Malek; Ethan M. Shevach

It is clear that macrophages serve as antigen-presenting cells for a variety of specific immune responses and that many antigens are presented by macrophages to T lymphocytes in the context of the products of the I region of the major histocompatibility gene complex (MHC) of a species. For example, I-region-controlled genetic restrictions have been described for the development and expression of helper T cells (Erb and Feldmann, 1975a; Marrack and Kappler, 1978), for T-lymphocyte proliferation (Rosenthal and Shevach, 1976 Schwartz et al., 1978), and for delayed-type hypersensitivity (Miller, 1978). The use of recombinant and congenic mice and inbred guinea pigs has been an invaluable tool in establishing the role of the I region in antigen presentation. Furthermore, alloantisera to I-region gene products have demonstrated the necessity for the expression of Ia antigens on the surface of macrophages (Yamashita and Shevach, 1977; Cowing et al., 1978). The ability of multispecific anti-Ia sera to produce marked inhibition of in vitro antigen-specific T-lymphocyte proliferation to conventional and immune response (Ir) gene-controlled antigens (Shevach, 1978) indicated that a complex of Ia antigens and the nominal antigen was seen by the T lymphocyte.


Journal of Experimental Medicine | 1984

T cell-activating properties of an anti-thy-1 monoclonal antibody: possible analogy to okt3/leu-4.

Kurt C. Gunter; Thomas R. Malek; Ethan M. Shevach


Journal of Experimental Medicine | 1986

Role of Ly-6 in lymphocyte activation. II. Induction of T cell activation by monoclonal anti-Ly-6 antibodies.

Thomas R. Malek; G Ortega; Christina Chan; Richard A. Kroczek; Ethan M. Shevach


Journal of Experimental Medicine | 1983

Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I.

Maureen Howard; Louis A. Matis; Thomas R. Malek; Ethan M. Shevach; Wayne Kell; David I. Cohen; Kenji Nakanishi; William E. Paul


Journal of Experimental Medicine | 1984

Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis.

Kenji Nakanishi; Thomas R. Malek; Kendall A. Smith; Toshiyuki Hamaoka; Ethan M. Shevach; William E. Paul


Journal of Experimental Medicine | 1985

Interleukin 2 upregulates expression of its receptor on a T cell clone.

Thomas R. Malek; Jonathan D. Ashwell


Journal of Experimental Medicine | 1986

Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens

Toshiaki Mizuochi; S Ono; Thomas R. Malek; Alfred Singer


European Journal of Immunology | 1983

The cellular compartmentalization of macrophage-associated nominal antigen: immunologically relevant macrophage-associated antigen may not require an intracellular phase of macrophage handling.

Thomas R. Malek; Loran T. Clement; Ethan M. Shevach


European Journal of Immunology | 1982

Nature of the antigenic complex recognized by T lymphocytes. IX. Direct immunochemical demonstration of nominal antigen on the macrophage cell surface

Thomas R. Malek; Ethan M. Shevach

Collaboration


Dive into the Thomas R. Malek's collaboration.

Top Co-Authors

Avatar

Ethan M. Shevach

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alfred Singer

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Toshiaki Mizuochi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maureen Howard

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Christina Chan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

David I. Cohen

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

G Ortega

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jonathan D. Ashwell

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Kendall A. Smith

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge